TBIO Stock Summary and Trading Ideas (Telesis Bio | NASDAQ:TBIO)

Telesis Bio Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services. Its products comprise of BioXp system, BioXp kits, Benchtop reagents and BioXp biofoundry services.

Telesis Bio trades on the NASDAQ stock market under the symbol TBIO.

As of April 23, 2024, TBIO stock price climbed to $0.32 with 135,084 million shares trading.

TBIO has a beta of 2.56, meaning it tends to be more sensitive to market movements. TBIO has a correlation of 0.05 to the broad based SPY ETF.

TBIO has a market cap of $9.74 million. This is considered a Sub-Micro Cap stock.

Last quarter Telesis Bio reported $7 million in Revenue and -$.23 earnings per share. This fell short of revenue expectation by $-23,000 and missed earnings estimates by -$.01.

The top ETF exchange traded funds that TBIO belongs to (by Net Assets): VTI, VXF, IWC.

TBIO has underperformed the market in the last year with a price return of -87.4% while the SPY ETF gained +24.3%. TBIO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -0.8% and -24.9%, respectively, while the SPY returned +4.9% and -2.5%, respectively.

TBIO support price is $.28 and resistance is $.35 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TBIO stock will trade within this expected range on the day.